FdaApplication
NDA 011878
Identifiers
- fda_app_no: NDA011878
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SERPASIL-ESIDRIX #1 | HYDROCHLOROTHIAZIDE; RESERPINE | 25MG;0.1MG | TABLET;ORAL |
| SERPASIL-ESIDRIX #2 | HYDROCHLOROTHIAZIDE; RESERPINE | 50MG;0.1MG | TABLET;ORAL |
2 products